| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2021 | May 4, 2021 | Werewolf Therapeutics, Inc. | Director | Buy | 100.0 | +400,000 | 24.29% | ✗ | $6.4M |
| Apr 13, 2020 | Apr 13, 2020 | Keros Therapeutics, Inc. | Director | Buy | 95.0 | +120,000 | 6.26% | ✗ | $1.9M |